PAS
GSK icon

Park Avenue Securities’s GSK GSK Stock Holding History

Park Avenue Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
39,088
+143
+0.4% +$7.56K 0.01% 666
2026
Q1 		$2.15M Sell
38,945
-13,775
-26% -$746K 0.02% 529
2025
Q4 		$2.58M Sell
52,720
-1,791
-3% -$83.5K 0.02% 459
2025
Q3 		$2.35M Sell
54,511
-40,832
-43% -$1.59M 0.02% 528
2025
Q2 		$3.66M Buy
95,343
+17,713
+23% +$677K 0.03% 339
2025
Q1 		$3.01M Buy
77,630
+25,111
+48% +$919K 0.04% 295
2024
Q4 		$1.78M Sell
52,519
-7,722
-13% -$278K 0.02% 525
2024
Q3 		$2.46M Sell
60,241
-12,940
-18% -$529K 0.03% 378
2024
Q2 		$2.82M Buy
73,181
+7,430
+11% +$313K 0.03% 323
2024
Q1 		$2.82M Buy
65,751
+5,105
+8% +$211K 0.04% 307
2023
Q4 		$2.25M Buy
60,646
+16,829
+38% +$604K 0.03% 342
2023
Q3 		$1.59M Buy
43,817
+3,419
+8% +$121K 0.02% 402
2023
Q2 		$1.44M Buy
40,398
+4,788
+13% +$172K 0.02% 405
2023
Q1 		$1.27M Buy
35,610
+5,170
+17% +$181K 0.02% 397
2022
Q4 		$1.07M Buy
30,440
+1,416
+5% +$47.2K 0.02% 493
2022
Q3 		$854K Buy
29,024
+596
+2% +$22.6K 0.02% 516
2022
Q2 		$1.55M Buy
28,428
+5,373
+23% +$297K 0.03% 321
2022
Q1 		$1.25M Buy
23,055
+5,713
+33% +$310K 0.02% 401
2021
Q4 		$956K Buy
17,342
+7,844
+83% +$408K 0.02% 492
2021
Q3 		$454K Buy
9,498
+2,036
+27% +$102K 0.01% 678
2021
Q2 		$371K Buy
7,462
+1,336
+22% +$64.2K 0.01% 759
2021
Q1 		$273K Sell
6,126
-237
-4% -$10.8K 0.01% 812
2020
Q4 		$293K Sell
6,363
-6,573
-51% -$302K 0.01% 695
2020
Q3 		$609K Sell
12,936
-774
-6% -$38.8K 0.02% 389
2020
Q2 		$699K Sell
13,710
-597
-4% -$30.6K 0.03% 263
2020
Q1 		$678K Buy
14,307
+1,306
+10% +$69.7K 0.06% 109
2019
Q4 		$764K Buy
13,001
+1,796
+16% +$99.9K 0.03% 219
2019
Q3 		$598K Sell
11,205
-285
-2% -$14.7K 0.03% 219
2019
Q2 		$575K Buy
11,490
+353
+3% +$17.7K 0.06% 111
2019
Q1 		$582K Sell
11,137
-149
-1% -$7.45K 0.03% 195
2018
Q4 		$556K Sell
11,286
-1,230
-10% -$60.6K 0.09% 74
2018
Q3 		$627K Buy
12,516
+496
+4% +$25.2K 0.1% 71
2018
Q2 		$603K Buy
12,020
+6,067
+102% +$306K 0.11% 65
2018
Q1 		$289K Buy
5,953
+801
+16% +$37.3K 0.06% 97
2017
Q4 		$238K Sell
5,152
-4,221
-45% -$195K 0.06% 97
2017
Q3 		$479K Buy
9,373
+2,471
+36% +$125K 0.15% 36
2017
Q2 		$369K Buy
+6,902
New +$368K 0.04% 104
2017
Q1 		– Sell
-4,930
Closed -$239K – 61
2016
Q4 		$239K Buy
4,930
+967
+24% +$47.8K 0.12% 41
2016
Q3 		$214K Buy
+3,963
New +$217K 0.13% 42

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM

Park Avenue Securities's GSK Position: Q2 2026 in Review

Park Avenue Securities increased its GSK (GSK) stake by 0.37% in Q2 2026, buying an estimated $7.56K and bringing the position to 39,088 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #666.

Park Avenue Securities first reported a position in GSK in Q3 2016 and has held it in 39 quarters since. The position peaked at $3.66M in Q2 2025. 296 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Park Avenue Securities held 39,088 shares of GSK worth $2.05M as of Q2 2026.
  • Park Avenue Securities bought 143 GSK shares in Q2 2026, an estimated $7.56K.
  • GSK made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #666 holding.
  • Park Avenue Securities first reported a position in GSK in Q3 2016 and has held it in 39 quarters since.
  • Park Avenue Securities's GSK position peaked at $3.66M in Q2 2025.
  • 296 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.